• Publications
  • Influence
Pretreatment assessment of tumor enhancement on contrast‐enhanced computed tomography as a potential predictor of treatment outcome in metastatic renal cell carcinoma patients receiving
Tumor vascularity is a potential predictor of treatment outcomes in metastatic renal cell carcinoma (mRCC), and contrast enhancement of tumors in computed tomography (CT) is correlated significantlyExpand
  • 53
  • 5
Keynote 057: Phase II trial of Pembrolizumab (pembro) for patients (pts) with high-risk (HR) nonmuscle invasive bladder cancer (NMIBC) unresponsive to bacillus calmette-guérin (BCG).
350Background: The PD-1 inhibitor pembro has durable antitumor activity in pts with metastatic urothelial carcinoma. Upregulation of the PD-1 pathway has been observed in BCG-resistant NMIBC, sugge...
  • 22
  • 4
Prostate stem cell antigen mRNA in peripheral blood as a potential predictor of biochemical recurrence in high-risk prostate cancer.
OBJECTIVE To determine whether the presence of prostate stem cell antigen (PSCA) mRNA in peripheral blood can predict biochemical recurrence (BCR) after radical prostatectomy in patients withExpand
  • 36
  • 4
Risk of Second Primary Cancer among Prostate Cancer Patients in Korea: A Population-Based Cohort Study
As patients with prostate cancer have a long life expectancy, there is increasing interest in predicting the risk of development of a second primary cancer (SPC), and we therefore designed this studyExpand
  • 17
  • 4
Haplotype analysis of prostate stem cell antigen and association with prostate cancer risk.
PURPOSE Prostate stem cell antigen has become a promising target as a potential biomarker for prostate cancer, but to our knowledge there are no reports of a genetic variation of the PSCA geneExpand
  • 17
  • 4
The outcome with ureteric stents for managing non‐urological malignant ureteric obstruction
To investigate the clinical outcome using ureteric stents to manage ureteric obstruction in advanced non‐urological malignancies.
  • 28
  • 3
Overexpression of ERG and Wild-Type PTEN Are Associated with Favorable Clinical Prognosis and Low Biochemical Recurrence in Prostate Cancer
Objectives The aim of this study was to investigate the expression of two commonly altered genes ERG and PTEN in prostate cancer (PC) and evaluate their prognostic significance. Despite conflictingExpand
  • 36
  • 3
Immune checkpoint inhibitors for urothelial carcinoma
  • H. Kim, H. Seo
  • Medicine
  • Investigative and clinical urology
  • 31 August 2018
Urothelial carcinoma (UC), originating in the bladder or upper urinary tract, is the most common histological type of cancer. Currently, platinum-based cytotoxic chemotherapy is the standardExpand
  • 30
  • 2
Detection of Human Papillomavirus Infection and p16 Immunohistochemistry Expression in Bladder Cancer with Squamous Differentiation
Objectives To determine the potential association between HPV infection and the squamous cell component of urothelial carcinoma (UC) of the bladder and to validate p16 overexpression as a surrogateExpand
  • 20
  • 2
Reverse transcriptase‐polymerase chain reaction and immunohistochemical studies for detection of prostate stem cell antigen expression in prostate cancer: Potential value in molecular staging of
Objectives:  To determine whether detection of prostate stem cell antigen (PSCA) expression has potential for molecular staging in prostate cancer (PCa), we examined the relationship betweenExpand
  • 18
  • 2